HealthDay News — Popular chatbots generally perform well in responding to very high-risk and very low-risk questions about suicide, according to a study published online August 26 in Psychiatric ...

HealthDay News — People who have had COVID-19 have an increased risk for developing certain new-onset type 2 inflammatory diseases of the airways, while receipt of a COVID-19 vaccine reduces the risk, ...

HealthDay News — Spironolactone does not reduce a composite outcome of cardiovascular mortality and hospitalization due to heart failure among patients receiving maintenance dialysis, according to a ...

Saroglitazar is a novel peroxisome proliferator-activated receptor alpha/gamma agonist designed to target both bile acid toxicity and liver inflammation.

COVID-19 vaccine approvals; CDC leadership in turmoil; orforglipron weight loss trial results; Ixchiq license suspended by FDA; REMS updated for Filspari.

Elevated circulating trimethylamine N-oxide also linked to recommended surgical intervention for abdominal aortic aneurysms.

Later in a statement Mr Zaid, with his fellow attorney Abbe Lowel, wrote that Dr Monarez “refused to rubberstamp unscientific, reckless directives” and “has neither resigned nor received notification ...

HBOT uses a pressurized chamber to deliver 100% oxygen, helping the lungs absorb more oxygen to support healing and fight infections, according to the FDA.

HealthDay News — Both the Nail Psoriasis Severity Index (NAPSI) and the Nijmegen-Nail Psoriasis Activity Index Tool (N-NAIL) provide accurate cutoffs for diagnosing nail psoriasis, with better ...

Research shows the campaign led to millions of attempts to stop smoking and more than 1 million long-term quits ...

The 7-year analysis also demonstrated sustained invasive disease-free survival and distant relapse-free survival benefit.

The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and mNexspike ®. The updated mRNA vaccines target the LP.8.1 variant of ...